Stephen Gordon, Chief Financial Officer at TransMedics Group, Inc. (TMDX), sold 4,120 shares at $135.93 ($560K) on 2024-06-03, disclosed to the SEC on 2024-06-05.
Scheduled sale ($560k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $135.93 | 2,060 | $280K | 50.0% |
| 2 | $135.93 | 2,060 | $280K | 50.0% |
| Total | $135.93 avg | 4,120 | $560K | 100% |
| Filing → |
| TMDX | SELL | 2024-04-02 | $1.1M | — | Filing → |
| TMDX | SELL | 2024-03-12 | $334K | — | Filing → |
| TMDX | SELL | 2024-03-05 | $1.2M | — | Filing → |